The Efficiencies Defense: What Would High Court Do?
Law360, New York (May 22, 2017, 10:32 AM EDT) -- Over the past two years, Anthem’s proposed acquisition of Cigna has generated a seemingly endless series of headlines regarding the companies’ antitrust defense, internal power struggles, and, most recently, Anthem’s fight to keep the deal alive. Despite filing an appeal to the U.S. Supreme Court — Anthem’s last shot at overturning the injunction prohibiting the transaction — Anthem officially called off the $54 billion deal recently, effectively mooting the cert petition. In addition to signaling the end of one of the most watched antitrust litigations in recent memory, the move also leaves unanswered several important questions Anthem had raised regarding the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!